CrossrefInfokarte
Efficacy and safety of chimeric antigen receptor T-cell therapy versus standard treatment in hemato-oncology: A systematic review and meta-analysis
European Journal of Cancer · 2026-12 · 249 · 117820
DOI: 10.1016/j.ejca.2026.117820 ↗Abstract
Kein Abstract verfügbar.
EUVIMED